Maplight Therapeutics lists RSU-linked proposed sales

Maplight Therapeutics, Inc. submission lists proposed sales of Common Stock under Form 144.

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. submission lists proposed sales of Common Stock under Form 144. The excerpt shows Restricted Stock Unit grants of 3,200 shares (07/30/2023), 1,434 shares (11/09/2023), and 6,147 shares (05/02/2024). A securities line also shows the numbers 4,896, 132,289.92, and 42,440,000 with an apparent date of 04/15/2026.

Insights

Securities Counsel

Form 144 lists proposed resale of restricted/common shares tied to RSU grants.

Form 144 is a notice required when an affiliate proposes to sell restricted or control securities. The excerpt identifies three RSU grant amounts and a securities line with numeric items; it does not state sale mechanics, prices, or proceeds.

Timing and cash‑flow treatment are not detailed in the excerpt; subsequent broker filings or Form 4/5 may show executed transactions or proceeds.

Key Figures

RSU grant (07/30/2023): 3,200 shares RSU grant (11/09/2023): 1,434 shares RSU grant (05/02/2024): 6,147 shares +3 more

6 metrics

RSU grant (07/30/2023) 3,200 shares Restricted Stock Unit Grant dated 07/30/2023

RSU grant (11/09/2023) 1,434 shares Restricted Stock Unit Grant dated 11/09/2023

RSU grant (05/02/2024) 6,147 shares Restricted Stock Unit Grant dated 05/02/2024

Securities line number 4,896 Numeric entry in securities information line

Securities line number 132,289.92 Numeric entry in securities information line

Securities line number 42,440,000 Numeric entry in securities information line

Key Terms

Restricted Stock Unit (RSU), Form 144, Resale of restricted securities

3 terms

Restricted Stock Unit (RSU) financial

"Restricted Stock Unit Grant | Maplight Therapeutics, Inc."

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

Form 144 regulatory

"CONTENT TO ANALYZE: ... form_type: "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Resale of restricted securities regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MPLT Form 144 excerpt show about shares to be sold?

The excerpt shows proposed sales tied to RSUs of 3,200, 1,434, and 6,147 shares dated 07/30/2023, 11/09/2023, and 05/02/2024. It lists a securities line with additional numeric values but does not detail sale execution or proceeds.

Are the RSU grant dates and amounts for MPLT explicitly listed?

Yes. The excerpt lists Restricted Stock Unit grants of 3,200 shares on 07/30/2023, 1,434 shares on 11/09/2023, and 6,147 shares on 05/02/2024. No vesting or exercise prices are provided in the excerpt.

Does the excerpt state how proceeds from the MPLT sales will be used?

No. The provided text does not state any use of proceeds or who will receive cash. It lists securities and numeric values but does not describe proceeds, pricing, or allocation of sale proceeds.

What do the numbers 4,896, 132,289.92, and 42,440,000 refer to in the excerpt?

Those numbers appear on the securities line as 4,896, 132,289.92, and 42,440,000 with a date 04/15/2026. The excerpt does not attach explicit labels to these figures, so their exact meaning is not specified here.

Does this Form 144 excerpt show completed sales of MPLT shares?

No. Form 144 provides notice of proposed sales by affiliates; the excerpt lists intended sale details but does not confirm that any sales were executed or report transaction prices or dates of sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:14 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001728746
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 CHESAPEAKE DRIVE REDWOOD CITY CALIFORNIA 94063
Phone	650-839-4360
Name of Person for Whose Account the Securities are To Be Sold	Lillie James Woodruff
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Avenue 4th Floor New York NY 10022	4896	132289.92	42440000	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			3200	07/30/2023	N/A
Common	11/09/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			1434	11/09/2023	N/A
Common	05/02/2024	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			6147	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	04/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	James Lillie
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)